What Paesel + Lorei does

Paesel + Lorei GmbH & Co. KG is a privately held, family-run German pharmaceutical services company founded in 1965 in Frankfurt am Main and headquartered in Rheinberg, North Rhine-Westphalia. The company provides GDP-compliant wholesale and distribution, GMP-compliant contract manufacturing and secondary packaging (§13.1 AMG), pharmaceutical import under §73.3 AMG, clinical study supply, customs warehousing (Type C / ATLAS), 24/7 emergency delivery, and marketing authorization holder services. Its proprietary product is Impavido (miltefosine), an orphan drug for leishmaniasis acquired as marketing authorization holder in 2016. Distribution agreements include therapy allergens from Italian manufacturer Lofarma SpA (signed December 2022) and veterinary medicinal products authorized in 2023 under EU Regulation 2019/6.

The technology stack centers on the ALPHAPLAN ERP system (customized for pharmaceutical wholesale and migrated in May 2020 after 14 months of GMP/GDP validation), Securpharm/ACS data matrix serialization for EU Falsified Medicines Directive compliance, NGDA N-Ident pharmacy server connectivity, and climate-controlled warehousing spanning +2 to +8 °C refrigerated and +15 to +25 °C ambient zones with 1 °C warning limits. A patented special foil technology supports relabeling of blister strips and bottles for batch sizes from a few hundred to 40,000 units. Regulatory scope spans GMP, GDP, ISO 9001:2015, §52a AMG wholesale, §13.1 AMG manufacturing, §3 BTMG narcotics, and §4 MedCanG medical cannabis.

Revenue is generated through transactional distribution fees (€1.65 plus VAT per order), quote-based contract manufacturing and packaging, import clearance services, licensing/royalties on the Impavido marketing authorization, managed logistics outsourcing, and emergency courier services. Go-to-market is direct enterprise field sales to public pharmacies, hospital and university pharmacies, and pharmaceutical manufacturers in Germany, with European and international reach for clinical study supply and export. The company is a full member of B.A.H, BPI, and Healthcare Frauen industry associations, and counts Tilray as a Canadian cannabis contract manufacturer. Leadership is held by Managing Director/Shareholder Dr. Anne Pfitzner-Lorei and CEO Naime Gök.

Name

Paesel + Lorei

Legal name

Paesel + Lorei GmbH & Co. KG

Website

https://paesel-lorei.de

Company type

Private

Founded year

1965

Operating status

Operating

Headcount range

11–50 employees

Short description

Paesel + Lorei is a family-run German pharmaceutical services company providing GDP-compliant wholesale, GMP-compliant contract manufacturing and packaging, import, clinical study supply, and marketing authorization holding (including the orphan drug Impavido) to pharmacies, hospitals, and pharma manufacturers in Germany and Europe.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale and Distribution Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Pharmaceutical Preparation Manufacturing (325412)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Compounding Ingredient & API Distributors (Pharma Supply) (HLAIAJAO)

akta.pro secondary industries

Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Anti-Counterfeit & Track-and-Trace Packaging (Serialization, Security Features) (IMALAIAJ)

Keywords

• Pharmaceutical wholesale
• Pharmaceutical distribution
• Contract manufacturing
• Pharmaceutical logistics
• GDP-compliant supply

Headquarters

HQ city

Rheinberg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Pharmaceutical Wholesale and Distribution: Distribution of imported and domestic pharmaceuticals, narcotics, and OTC products to public pharmacies and hospital pharmacies. GDP-compliant supply chain services.
2. Contract Manufacturing and Packaging: Secondary packaging services (§13.1 AMG) including labeling, repackaging, and serialization for batches from hundreds to 40,000 units
3. Import Services: Import of foreign pharmaceutical specialities (§73.3 AMG) including customs clearance for public and hospital pharmacies
4. Marketing Authorization Holder Services: Distribution of licensed products including Impavido (Miltefosine) as marketing authorization holder
5. Logistics Outsourcing Services: Outsourcing services for pharmaceutical logistics including warehousing, distribution, clinical study supply, sample shipment, and advertising material logistics
6. Emergency Delivery Services: 24/7 emergency shipment services including courier, on-board courier, and helicopter delivery for urgent pharmaceutical needs

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

Paesel + Lorei is a German pharmaceutical service company that imports, wholesales, and distributes medicinal products (including narcotics, OTC, and medical cannabis) to public and hospital pharmacies. It also provides GMP-compliant contract manufacturing and secondary packaging (§13.1 AMG), marketing authorization holder services (including Impavido/miltefosine), customs warehousing (Type C), clinical study supply, sample shipment, advertising material logistics, and 24/7 emergency delivery of pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

• Impavido: Paesel + Lorei's proprietary pharmaceutical product containing Miltefosine as active ingredient, approved as an orphan drug for the treatment of leishmaniasis (a parasitic tropical disease). The company is the Marketing Authorization Holder for this product.
• Bealaré No1
• Syltaré

Products and services

• Pharmaceutical Wholesale and Distribution GDP-compliant distribution of imported and domestic pharmaceuticals, narcotics, and OTC products to public pharmacies, hospital pharmacies, and university pharmacies across Germany and internationally.
• Pharmaceutical Import Services Sourcing and import of foreign pharmaceutical specialities (§73.3 AMG) including customs clearance and legal basis review prior to import, for public and hospital pharmacies.
• Contract Manufacturing and Packaging GMP-compliant secondary packaging (labeling, repackaging, serialization) of pharmaceuticals under §13.1 AMG, with batch capacities from a few hundred up to 40,000 units, for pharmaceutical manufacturers.
• Impavido (Miltefosine) Marketing Authorization Holder Services Distribution of Impavido (miltefosine), an orphan drug for leishmaniasis treatment, as the company's proprietary licensed product.
• Clinical Study Pharmaceutical Supply GDP-compliant supply of investigational medicinal products and clinical trial materials to pharmaceutical research institutions, hospital pharmacies, and university pharmacies.
• Sample Shipment and Advertising Material Logistics Outsourced distribution of physician samples and pharmaceutical advertising materials in compliance with §47 AMG for pharmaceutical marketing companies.
• Customs Warehouse Services (Type C) Duty-unpaid intermediate storage (Zolllager Type C) of imported pharmaceuticals using ATLAS IT customs procedure, supporting import/export operations.
• 24/7 Emergency Pharmaceutical Delivery 24/7 emergency shipment of pharmaceuticals using courier, on-board courier, and helicopter delivery for urgent clinical and patient needs.
• International Pharmaceutical Export Export of pharmaceuticals to the EU and third countries, including clinical study supply worldwide with direct shipment within 24-48 hours across Europe.
• Veterinary Medicinal Products Wholesale Wholesale distribution of veterinary medicinal products under Article 99 of EU Regulation 2019/6, following successful LANUV inspection.

Quantifiable outcome

• Direct shipment within 24-48 hours across Europe
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Lofarma SpAcoreChannel Partner/ Reseller/ Distributor · 6 December 2022Paesel + Lorei is the new distribution partner for Lofarma SpA in Germany for therapy allergens (Lais Cat, Alternaria, Mugwort, Pellitory, Ragweed). Ensures continued availability of these allergy immunotherapy products for patients in Germany.
• B.A.H e.V.minorOthers · 24 October 2016Full member since October 24, 2016. Active participation in working groups including computer validation, contract handbook, SOPs in GMP area, and QM handbook.
• BPI e.V.minorOthers · 1 June 2016Full member since June 2016. German pharmaceutical industry association for pharmaceutical companies.
• CVS (ALPHAPLAN)coreTechnology or IntegrationALPHAPLAN ERP implementation partner. Customized ERP system for pharmaceutical wholesale and logistics requirements including narcotics tracking and batch-level traceability.
• Securpharm and ACScoreTechnology or IntegrationMembership in Securpharm and ACS for EU Falsified Medicines Directive compliance. Enables serialization code upload/download for counterfeit protection.
• NGDA (Netzgesellschaft Deutscher Apotheker)coreTechnology or IntegrationRegistered participant in NGDA N-Ident procedure for pharmacy server connection. Supports implementation of Falsified Medicines Directive for both pharmaceutical entrepreneur and international wholesaler.
• Healthcare Frauen EVminorOthersAssociation membership supporting women in healthcare/pharmaceutical industry.
• RentokilminorOthersPest control service provider for monitoring and protection against rodents and flying insects in warehousing areas.

Scale indicators5 records

Recent moves12 records

Expansion highlights6 records

Broad incumbents

• Phoenix Group: One of Europe's largest pharmaceutical wholesalers and pharmacy services operators with deep German footprint; comparable in wholesale/distribution but at significantly larger scale and broader geographic reach.
• Alliance Healthcare Germany (Walgreens Boots Alliance): Major German pharmaceutical wholesaler (formerly Anzag/GEHE) and pharmacy services group; overlaps with Paesel + Lorei's wholesale and distribution activities but at vastly larger scale and broader portfolio.

Direct peers

• EVER Pharma GmbH: Specialty pharmaceutical company covering development, manufacturing and distribution of niche products including injectables; comparable in combining manufacturing, marketing authorization and distribution for niche indications.
• Aenova Holding GmbH: German pharmaceutical CDMO offering contract manufacturing and packaging services including serialization and GMP-compliant production; closely comparable to Paesel + Lorei's contract manufacturing/packaging line.
• EMRAmed GmbH: German pharmaceutical wholesaler specialized in parallel imports of foreign medicinal products to pharmacies and hospitals; directly comparable niche importer-wholesaler business model with similar customer base and GDP-compliant operations.
• CC Pharma GmbH: German specialty pharmaceutical wholesaler focused on imports, niche products and unlicensed/individual imports for pharmacies and hospitals; similar service portfolio including import, distribution, and parallel trade.
• HAEMATO PHARM AG: German specialty pharmaceutical wholesaler and licensed manufacturer serving pharmacies, hospitals and physicians with a focus on niche and imported products; similar mid-sized, specialty-focused operating profile.
• Temmler Pharma Service GmbH: German CDMO offering contract manufacturing, packaging and pharmaceutical services; comparable contract manufacturing/packaging and regulatory services positioned to pharmaceutical companies.

Regional players

• Herba Chemosan Apotheker-AG: Austrian pharmaceutical wholesaler with full-range distribution to pharmacies; comparable wholesale and distribution business model but focused on the Austrian/DACH market rather than Germany's import niche.

Emerging players

• CanPharma GmbH: German medical cannabis importer and distributor with wholesale authorization; overlaps with Paesel + Lorei's §4 MedCanG medical cannabis operations and EU import capabilities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Paesel + Lorei